ZNF681

gene
On this page

Also known as FLJ31526

Summary

ZNF681 (zinc finger protein 681, HGNC:26457) is a protein-coding gene on chromosome 19p12, encoding Zinc finger protein 681 (Q96N22). May be involved in transcriptional regulation.

This gene encodes a protein containing the krueppel associated box (KRAB) and zinc-finger domains, which may be involved in transcriptional regulation. Non-functional alleles of this gene are present in alternate genome assemblies including T2T-CHM13v1.1, resulting from a ‘TG’ deletion (rs61397759) which causes a frameshift and a premature stop codon.

Source: NCBI Gene 148213 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 94 total
  • MANE Select transcript: NM_138286

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:26457
Approved symbolZNF681
Namezinc finger protein 681
Location19p12
Locus typegene with protein product
StatusApproved
AliasesFLJ31526
Ensembl geneENSG00000196172
Ensembl biotypeprotein_coding
Entrez148213

Gene structure

Transcript identifiers

Ensembl transcripts: 4 — 4 protein_coding

ENST00000402377, ENST00000528059, ENST00000531570, ENST00000887419

RefSeq mRNA: 1 — MANE Select: NM_138286 NM_138286

CCDS: CCDS12414

Canonical transcript exons

ENST00000402377 — 4 exons

ExonStartEnd
ENSE000019491132373919523745323
ENSE000022463952375542523755551
ENSE000022785652375874723758891
ENSE000035908522375482323754918

Expression profiles

Bgee: expression breadth ubiquitous, 166 present calls, max score 83.84.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 5.0464 / max 111.2585, expressed in 1127 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
1802813.4325990
1802801.6139629

Top tissues by expression

240 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099183.84gold quality
ganglionic eminenceUBERON:000402379.44gold quality
cortical plateUBERON:000534378.97gold quality
ventricular zoneUBERON:000305378.44gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047378.00gold quality
adrenal tissueUBERON:001830373.46gold quality
calcaneal tendonUBERON:000370171.79gold quality
islet of LangerhansUBERON:000000671.59gold quality
upper leg skinUBERON:000426268.75gold quality
rectumUBERON:000105266.54gold quality
lymph nodeUBERON:000002965.81gold quality
cerebellar cortexUBERON:000212964.37gold quality
cerebellar hemisphereUBERON:000224564.27gold quality
prefrontal cortexUBERON:000045164.22gold quality
cerebellumUBERON:000203763.56gold quality
lower esophagus mucosaUBERON:003583463.31gold quality
smooth muscle tissueUBERON:000113563.22gold quality
bone marrow cellCL:000209263.07silver quality
pancreasUBERON:000126463.04gold quality
right hemisphere of cerebellumUBERON:001489062.82gold quality
esophagus mucosaUBERON:000246962.51gold quality
stromal cell of endometriumCL:000225561.61gold quality
vermiform appendixUBERON:000115461.52gold quality
Brodmann (1909) area 9UBERON:001354061.10gold quality
tendonUBERON:000004359.88gold quality
skin of hipUBERON:000155459.86gold quality
olfactory segment of nasal mucosaUBERON:000538659.73gold quality
dorsolateral prefrontal cortexUBERON:000983459.70gold quality
tibiaUBERON:000097959.60silver quality
thymusUBERON:000237059.60silver quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no4.17

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

216 targeting ZNF681, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-190A-3P100.0080.355520
HSA-MIR-3163100.0077.238605
HSA-MIR-3064-3P100.0070.091254
HSA-MIR-656-3P100.0072.152788
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-4795-3P100.0074.624024
HSA-MIR-5692A100.0074.406850
HSA-MIR-5011-5P100.0083.465820
HSA-MIR-4776-3P100.0068.731340
HSA-LET-7A-3P100.0074.033932
HSA-LET-7B-3P100.0074.083913
HSA-LET-7F-1-3P100.0074.023928
HSA-MIR-98-3P100.0074.083907
HSA-MIR-340-5P100.0072.504437
HSA-MIR-4789-3P99.9970.752484
HSA-MIR-371B-5P99.9975.344759
HSA-MIR-548AW99.9972.573559
HSA-MIR-428299.9975.366408
HSA-MIR-548C-3P99.9974.017587
HSA-MIR-366299.9973.825684
HSA-MIR-196A-1-3P99.9972.152772
HSA-MIR-1212199.9966.64255
HSA-MIR-453199.9969.703181
HSA-MIR-373-5P99.9875.364753
HSA-MIR-616-5P99.9875.584775
HSA-MIR-548N99.9871.944170
HSA-MIR-477599.9875.006394
HSA-MIR-1213699.9872.815713
HSA-MIR-4715-3P99.9866.03670
HSA-MIR-3688-3P99.9772.022834

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
mus_musculusZfp738ENSMUSG00000048280
mus_musculusZfp457ENSMUSG00000055341
mus_musculusZfp595ENSMUSG00000057842
mus_musculusZfp953ENSMUSG00000098905
rattus_norvegicusAABR07009105.1ENSRNOG00000053325

Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)

Protein

Protein identifiers

Zinc finger protein 681Q96N22 (reviewed: Q96N22)

All UniProt accessions (3): E9PJB6, E9PSC0, Q96N22

UniProt curated annotations — full annotation on UniProt →

Function. May be involved in transcriptional regulation.

Subcellular location. Nucleus.

Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.

Isoforms (2)

UniProt IDNamesCanonical?
Q96N22-11yes
Q96N22-22

RefSeq proteins (1): NP_612143* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001909KRABDomain
IPR013087Znf_C2H2_typeDomain
IPR036051KRAB_dom_sfHomologous_superfamily
IPR036236Znf_C2H2_sfHomologous_superfamily
IPR050331Zinc_finger_PRDM4/PRDM1/PRDM14Family

Pfam: PF00096, PF01352, PF13465

UniProt features (30 total): zinc finger region 16, sequence conflict 6, sequence variant 4, chain 1, domain 1, region of interest 1, splice variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q96N22-F166.830.08

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-212436Generic Transcription Pathway

MSigDB gene sets: 71 (showing top): MODULE_205, chr19p12, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C, KIM_MYCN_AMPLIFICATION_TARGETS_DN, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, GTF2E2_TARGET_GENES, MIR616_5P, MIR371B_5P, MIR373_5P, MIR548AJ_3P_MIR548X_3P, MIR335_3P, MIR548AE_3P_MIR548AQ_3P, MIR548AH_3P_MIR548AM_3P, MIR548J_3P

GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)

GO Molecular Function (5): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), metal ion binding (GO:0046872)

GO Cellular Component (1): nucleus (GO:0005634)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
RNA Polymerase II Transcription1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
RNA polymerase II transcription regulatory region sequence-specific DNA binding2
regulation of DNA-templated transcription1
transcription by RNA polymerase II1
DNA-templated transcription1
regulation of gene expression1
regulation of RNA biosynthetic process1
cis-regulatory region sequence-specific DNA binding1
chromatin1
DNA-binding transcription factor activity1
regulation of transcription by RNA polymerase II1
transition metal ion binding1
nucleic acid binding1
cation binding1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

282 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ZNF681OR52N4Q8NGI2540
ZNF681SYNGR4O95473471
ZNF681TIGD7Q6NT04471
ZNF681TIGD6Q17RP2446
ZNF681ERVV-1B6SEH8438
ZNF681RGPD3A6NKT7418
ZNF681CRYBG2Q8N1P7393
ZNF681NKAPLQ5M9Q1375
ZNF681CGASQ8N884348
ZNF681KLK9Q9UKQ9348
ZNF681RAB36O95755307
ZNF681VEZTQ9HBM0291
ZNF681ABCC12Q96J65289
ZNF681KLK12Q9UKR0277
ZNF681ACTBP02570277

IntAct

2 interactions, top by confidence:

ABTypeScore
ECE1ZNF681psi-mi:“MI:0915”(physical association)0.370

BioGRID (1): ZNF681 (Affinity Capture-MS)

ESM2 similar proteins: A6NK75, A6NNF4, A6NP11, A8MTY0, B4DXR9, C9JN71, O75346, O75373, O75437, O95780, P0CJ79, P0DKX0, P0DPD5, P17017, P17019, P17035, P17038, P35789, Q03923, Q03924, Q03936, Q03938, Q08AN1, Q5MCW4, Q5R9F0, Q5SXM1, Q68DY1, Q6JLC9, Q6P5C7, Q6ZMV8, Q6ZN06, Q6ZN08, Q6ZNA1, Q6ZNG1, Q76KX8, Q86V71, Q86XN6, Q8IYB9, Q8IYN0, Q8N4W9

Diamond homologs: A0A1W2PQL4, A6NK75, A6NN14, A6NNF4, A6NP11, A8MQ14, A8MTY0, A8MUV8, A8MXY4, B4DX44, B4DXR9, E9PYI1, O14628, O43345, O75290, O75346, O75373, O75437, O95780, P0CB33, P0DKX0, P0DPD5, P16373, P17019, P17038, P21506, P35789, P52736, P52738, P52744, Q03923, Q03924, Q03936, Q03938, Q05481, Q14586, Q14593, Q14929, Q15928, Q3KNS6

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

94 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance83
Likely benign5
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

834 predictions. Top by Δscore:

VariantEffectΔscore
19:23745321:TAA:Tacceptor_gain0.9900
19:23745324:C:CCacceptor_gain0.9900
19:23758742:CTCA:Cdonor_loss0.9900
19:23758743:TCAC:Tdonor_loss0.9900
19:23758744:CA:Cdonor_loss0.9900
19:23758745:ACCAT:Adonor_loss0.9900
19:23758746:C:Adonor_loss0.9900
19:23745320:ATAA:Aacceptor_gain0.9800
19:23754927:T:TCacceptor_gain0.9800
19:23758741:TCTCA:Tdonor_loss0.9800
19:23745319:AATAA:Aacceptor_gain0.9700
19:23754817:ACCT:Adonor_loss0.9700
19:23754818:CCTA:Cdonor_loss0.9700
19:23754819:CTA:Cdonor_loss0.9700
19:23754820:TA:Tdonor_loss0.9700
19:23754821:ACC:Adonor_loss0.9700
19:23754822:C:CGdonor_loss0.9700
19:23754903:T:Cacceptor_gain0.9700
19:23745213:A:Cdonor_gain0.9500
19:23755464:T:Adonor_gain0.9500
19:23758745:A:ACdonor_gain0.9500
19:23758746:C:CCdonor_gain0.9500
19:23758780:G:Cdonor_gain0.9500
19:23745322:AAC:Aacceptor_loss0.9400
19:23745323:ACTG:Aacceptor_loss0.9400
19:23745324:CTGAA:Cacceptor_loss0.9400
19:23754915:ATACC:Aacceptor_loss0.9400
19:23754916:TACCT:Tacceptor_loss0.9400
19:23754917:AC:Aacceptor_loss0.9400
19:23754918:CC:Cacceptor_loss0.9400

AlphaMissense

4313 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
19:23743837:A:CF571L0.983
19:23743837:A:TF571L0.983
19:23743839:A:GF571L0.983
19:23743753:A:CF599L0.973
19:23743753:A:TF599L0.973
19:23743755:A:GF599L0.973
19:23743921:A:CF543L0.973
19:23743921:A:TF543L0.973
19:23743923:A:GF543L0.973
19:23744425:A:CF375L0.973
19:23744425:A:TF375L0.973
19:23744427:A:GF375L0.973
19:23744509:A:CF347L0.970
19:23744509:A:TF347L0.970
19:23744511:A:GF347L0.970
19:23744089:A:CF487L0.966
19:23744089:A:TF487L0.966
19:23744091:A:GF487L0.966
19:23744005:G:CF515L0.956
19:23744005:G:TF515L0.956
19:23744007:A:GF515L0.956
19:23743832:T:GQ573P0.953
19:23744341:A:CF403L0.953
19:23744341:A:TF403L0.953
19:23744343:A:GF403L0.953
19:23755516:G:CF13L0.951
19:23755516:G:TF13L0.951
19:23755518:A:GF13L0.951
19:23744173:A:CF459L0.950
19:23744173:A:TF459L0.950

dbSNP variants (sampled 300 via entrez): RS1000055536 (19:23743283 C>T), RS1000160105 (19:23747279 A>T), RS1000191898 (19:23752338 C>A), RS1000250786 (19:23751671 T>C), RS1000331581 (19:23758561 G>A), RS1000586136 (19:23739275 A>G), RS1000849273 (19:23758071 G>A,T), RS1001130016 (19:23752502 A>G), RS1001420784 (19:23758244 A>G), RS1002143265 (19:23758687 G>A,C), RS1002163224 (19:23743932 C>T), RS1002195554 (19:23758861 G>A,C,T), RS1002224931 (19:23748951 C>CAA), RS1002336118 (19:23756077 G>T), RS1002446725 (19:23744983 T>C)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

30 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyreneaffects methylation, increases expression, increases methylation2
GSK-J4decreases expression1
methylmercuric chloridedecreases expression1
triphenyl phosphateaffects expression1
titanium dioxidedecreases expression1
hydroxyhydroquinonedecreases expression1
sodium arseniteincreases expression1
potassium chromate(VI)affects cotreatment, decreases expression1
epigallocatechin gallateaffects cotreatment, decreases expression1
avobenzonedecreases expression1
di-n-butylphosphoric acidaffects expression1
pentabromodiphenyl etherdecreases expression1
2-palmitoylglycerolincreases expression1
4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic aciddecreases expression1
Rosiglitazonedecreases reaction, increases expression1
Pioglitazonedecreases reaction, increases expression1
Troglitazonedecreases reaction, increases expression1
Hydrogen Peroxideincreases expression1
Tobacco Smoke Pollutiondecreases expression1
Tretinoindecreases expression1
Valproic Aciddecreases expression1
Vanadatesdecreases expression1
Cyclosporinedecreases expression1
Aflatoxin B1affects expression1
Aflatoxin M1decreases expression1
Antirheumatic Agentsincreases expression1
Copper Sulfateincreases expression1
Lactic Aciddecreases expression1
tert-Butylhydroperoxidedecreases reaction, increases expression1
Magnetite Nanoparticlesdecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.